ReviewToxics2026
Review on the Bioaccumulation, Trophic Magnification, and Aquatic Toxicology of PFAS: Perspectives from Molecular Structure.
Review in Toxics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Per- and polyfluoroalkyl substances (PFAS) are widely detected in aquatic environments, and their bioaccumulation, trophic magnification, and ecotoxicity have raised increasing concern. However, critical knowledge gaps remain regarding how differences in their molecular structures influence these processes and the mechanisms underlying such effects. This review synthesizes the current knowledge of the physicochemical properties, bioaccumulation, trophic magnification, and toxicity of PFAS in aquatic environments, with particular emphasis on the effects of the carbon-chain length, functional-group type, and acid or salt form. The current evidence generally indicates that long-chain PFAS exhibit higher bioaccumulation, trophic magnification, and toxicity than short-chain PFAS, largely because of their enhanced hydrophobicity, stronger protein-binding affinity, and slower elimination rates. As two major PFAS subclasses, perfluoroalkyl sulfonates (PFSAs) generally show higher bioaccumulation and toxicity than perfluoroalkyl carboxylates (PFCAs). For example, the bioaccumulation factor of perfluorooctane sulfonate (PFOS) is approximately two- to three fold higher than that of perfluorooctanoic acid (PFOA). Some ether-containing PFAS, developed as safer alternatives, also exhibit concerning ecological hazards, particularly a high potential for trophic magnification. In addition, acid form PFAS generally accumulate more readily and induce more severe toxic effects than their corresponding salt forms. These findings highlight the need to further improve structure-based frameworks for PFAS ecological risk assessment.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.